Daratumumab Plus Triplet Therapy for Transplant-Eligible Patients With Multiple Myeloma
Combination Therapy With Venetoclax in Resistant Multiple Myeloma
Early-Phase Trial of New Monoclonal Antibody Plus Pembrolizumab in Resistant Myeloma
Comparison of First-Line Treatments in Older Patients With Myeloma
How Does Facility and Provider Volume Impact Survival in Multiple Myeloma?
Comparing Health-Care Costs Across Lines of Therapy for Multiple Myeloma
Risk Assessment and Survival Prediction in Patients With Multiple Myeloma
Supportive Care for Older Adults With Myeloma: Underuse of Guideline Recommendations?
Insights on Individualizing Treatment of Patients with Multiple Myeloma
Redefining Value Propositions and Managed Care Considerations in Multiple Myeloma
Autologous Stem Cell Transplantation in Multiple Myeloma: Who, When, and How?
Role of Proteasome Inhibitor Therapy in a Patient with High-Risk Relapsing Multiple Myeloma
Vanderbilt-Ingram Cancer Center
Roswell Park Cancer Institute
Immunotherapy Clinical Trials at Fred Hutch Cancer Research Center
Multiple Myeloma Research Foundation (MMRF)
National Cancer Institute (NCI) - Supported Cancer Clinical Trials
The Leukemia and Lymphoma Society
International Myeloma Foundation (IMF)